HALF-YEAR FINANCIAL REPORT OF THE AB SCIENCE GROUP
AT 30 JUNE 2024
March 2025 Corporate Presentation
Last financial results
ANNUAL FINANCIAL REPORT OF THE AB SCIENCE GROUP
FOR THE YEAR ENDING 31 DECEMBER 2023
AB Science
Masitinib and AB8939 – Two compounds with breakthrough mechanism of action
- Home
- Company
- Science
- Pipeline
- News and Media
- Investors
- Masivet®
- Careers
- Contact